114.24MMarket Cap
LossP/E TTM
Repare Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-01-27The current valuation score of Repare Therapeutics Inc is 8.75, ranking 23 out of 394 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.57, which is -80.94% below the recent high of -0.30 and -12103.93% above the recent low of -191.21.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.